SEEKYO is a biotech company that provides chemotherapies without adverse effects. It develops a drug candidate that can specifically target solid tumors, such as pancreas, lung, triple-negative breast, colon, head and neck, while sparing healthy tissues. In addition, the company offers a molecular platform that can design targeting assembly in order to treat a given malignancy, based on its unique tumor-associated specificities.
|Employees (est.) (May 2020)||5|
SEEKYO total Funding
SEEKYO latest funding size
Time since last funding
|4 months ago|
|French Tech Acceleration Fund|
When was SEEKYO founded?
SEEKYO was founded in 2018.
Who are SEEKYO key executives?
SEEKYO's key executives are Oury Chetboun and Sebastien Papot.
How many employees does SEEKYO have?
SEEKYO has 5 employees.
Who are SEEKYO competitors?
Competitors of SEEKYO include LIPAC Oncology, ANKAA THERAPEUTICS and 7 Hills Pharma.
Where is SEEKYO headquarters?
SEEKYO headquarters is located at 4 Rue Carol Heitz, Poitiers.
Where are SEEKYO offices?
SEEKYO has an office in Poitiers.
How many offices does SEEKYO have?
SEEKYO has 1 office.
Receive alerts for 300+ data fields across thousands of companies